Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
Saved in:
| Title: | Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. |
|---|---|
| Authors: | He, Yonghan1 (AUTHOR), Khan, Sajid1 (AUTHOR), Huo, Zhiguang2 (AUTHOR), Lv, Dongwen1 (AUTHOR), Zhang, Xuan3 (AUTHOR), Liu, Xingui1 (AUTHOR), Yuan, Yaxia1 (AUTHOR), Hromas, Robert4 (AUTHOR), Xu, Mingjiang5 (AUTHOR), Zheng, Guangrong3 (AUTHOR), Zhou, Daohong1 (AUTHOR) zhoudaohong@cop.ufl.edu |
| Source: | Journal of Hematology & Oncology. 7/27/2020, Vol. 13 Issue 1, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 144783535 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22He%2C+Yonghan%22">He, Yonghan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khan%2C+Sajid%22">Khan, Sajid</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huo%2C+Zhiguang%22">Huo, Zhiguang</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lv%2C+Dongwen%22">Lv, Dongwen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xuan%22">Zhang, Xuan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Xingui%22">Liu, Xingui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yuan%2C+Yaxia%22">Yuan, Yaxia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hromas%2C+Robert%22">Hromas, Robert</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Mingjiang%22">Xu, Mingjiang</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Guangrong%22">Zheng, Guangrong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Daohong%22">Zhou, Daohong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> zhoudaohong@cop.ufl.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Hematology+%26+Oncology%22">Journal of Hematology & Oncology</searchLink>. 7/27/2020, Vol. 13 Issue 1, p1-24. 24p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=144783535 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13045-020-00924-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 24 StartPage: 1 Titles: – TitleFull: Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: He, Yonghan – PersonEntity: Name: NameFull: Khan, Sajid – PersonEntity: Name: NameFull: Huo, Zhiguang – PersonEntity: Name: NameFull: Lv, Dongwen – PersonEntity: Name: NameFull: Zhang, Xuan – PersonEntity: Name: NameFull: Liu, Xingui – PersonEntity: Name: NameFull: Yuan, Yaxia – PersonEntity: Name: NameFull: Hromas, Robert – PersonEntity: Name: NameFull: Xu, Mingjiang – PersonEntity: Name: NameFull: Zheng, Guangrong – PersonEntity: Name: NameFull: Zhou, Daohong IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 07 Text: 7/27/2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 17568722 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Journal of Hematology & Oncology Type: main |
| ResultId | 1 |